Iovance Biotherapeutics (IOVA) Operating Leases (2019 - 2026)
Iovance Biotherapeutics' Operating Leases was $43.33 million in Q2 2026, down 3.9% from $45.1 million a year earlier and down 1.2% from the prior quarter.
Powered by 
Analysis
Iovance Biotherapeutics (IOVA) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Operating Leases at Iovance Biotherapeutics came in at $44.4 million, up 0.1% from FY2024.
- Operating Leases shows a five-year compound annual growth rate of -0.4% (FY2020 to FY2025).
- In earlier years, Operating Leases was $44.37 million in FY2024 (-33.9%), $67.09 million in FY2023 (-6.6%), $71.86 million in FY2022 (+9.8%) and $65.47 million in FY2021 (+44.3%).
- The Q2 2026 figure marks the lowest quarterly Operating Leases since Q3 2020.
- Compared with a year earlier, Operating Leases was higher in 1 of the last five quarters, with an average decline of 15.5%.
- The best year-over-year quarter for Operating Leases over five years was Q2 2022 (growth of 55.8%); the worst was Q1 2025 (a decline of 38.8%).
- Per Business Quant data, IOVA's Operating Leases in the three quarters before Q2 2026 was $43.88 million (Q1 2026), $44.4 million (Q4 2025) and $45.21 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Iovance Biotherapeutics | 3.74 Bn | 2.45 Bn | 73.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 42.77 Mn |
| Jun 30, 2026 | 43.33 Mn |
| Mar 31, 2026 | 43.88 Mn |
| Dec 31, 2025 | 44.40 Mn |
| Sep 30, 2025 | 45.21 Mn |
| Jun 30, 2025 | 45.10 Mn |
| Mar 31, 2025 | 44.22 Mn |
| Dec 31, 2024 | 44.37 Mn |
| Sep 30, 2024 | 66.39 Mn |
| Jun 30, 2024 | 69.25 Mn |
| Mar 31, 2024 | 72.29 Mn |
| Dec 31, 2023 | 67.09 Mn |
| Sep 30, 2023 | 68.01 Mn |
| Jun 30, 2023 | 68.84 Mn |
| Mar 31, 2023 | 69.61 Mn |
| Dec 31, 2022 | 71.86 Mn |
| Sep 30, 2022 | 71.94 Mn |
| Jun 30, 2022 | 73.00 Mn |
| Mar 31, 2022 | 71.18 Mn |
| Dec 31, 2021 | 65.47 Mn |
API Access
Iovance Biotherapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=IOVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "IOVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=IOVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();